Herborium HBRM Stock
Herborium Price Chart
Herborium HBRM Financial and Trading Overview
Herborium stock price | 0.0001 USD |
Previous Close | 0.0001 USD |
Open | 0.0001 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0001 - 0.0001 USD |
52 Week Range | 5.0E-5 - 0.0005 USD |
Volume | 3M USD |
Avg. Volume | 32.29M USD |
Market Cap | 220.29K USD |
Beta (5Y Monthly) | 89.50845 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HBRM Valuation Measures
Enterprise Value | 419.26K USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.8502277 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.618 |
Enterprise Value/EBITDA | -1.676 |
Trading Information
Herborium Stock Price History
Beta (5Y Monthly) | 89.50845 |
52-Week Change | -50.00000000000000000000000000000000% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0005 USD |
52 Week Low | 5.0E-5 USD |
50-Day Moving Average | 0.000105 USD |
200-Day Moving Average | 0.0001675 USD |
HBRM Share Statistics
Avg. Volume (3 month) | 32.29M USD |
Avg. Daily Volume (10-Days) | 6.48M USD |
Shares Outstanding | 2.2B |
Float | N/A |
Short Ratio | 0 |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | 0 |
Short % of Float | N/A |
Short % of Shares Outstanding | 0% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:1000 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | November 30, 2011 |
Most Recent Quarter (mrq) | August 31, 2012 |
Next Fiscal Year End | November 30, 2012 |
Profitability
Profit Margin | 26.32% |
Operating Margin (ttm) | -98.031% |
Gross Margin | 64.99% |
EBITDA Margin | -96.56% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 259.1K USD |
Revenue Per Share (ttm) | 0.44 USD |
Quarterly Revenue Growth (yoy) | 22.50% |
Gross Profit (ttm) | 125.4K USD |
EBITDA | -250200 USD |
Net Income Avi to Common (ttm) | 68.2K USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 120.1K USD |
Total Cash Per Share (mrq) | 0.2 USD |
Total Debt (mrq) | 539.3K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | -2.03 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Herborium
Country | United States |
State | NJ |
City | Fort Lee |
Address | One Bridge Plaza North |
ZIP | 07024 |
Phone | 201-849-4431 |
Website | https://www.herborium.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 2 |
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.
Q&A For Herborium Stock
What is a current HBRM stock price?
Herborium HBRM stock price today per share is 0.0001 USD.
How to purchase Herborium stock?
You can buy HBRM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Herborium?
The stock symbol or ticker of Herborium is HBRM.
Which industry does the Herborium company belong to?
The Herborium industry is Drug Manufacturers-Specialty & Generic.
How many shares does Herborium have in circulation?
The max supply of Herborium shares is 10.92B.
What is Herborium Price to Earnings Ratio (PE Ratio)?
Herborium PE Ratio is now.
What was Herborium earnings per share over the trailing 12 months (TTM)?
Herborium EPS is 0 USD over the trailing 12 months.
Which sector does the Herborium company belong to?
The Herborium sector is Healthcare.